product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Neuregulin-1 beta 1/NRG1 beta 1 ELISA
catalog :
DY377-05
quantity :
1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
price :
450 USD
more info or order :
citations: 20
Reference
Yun J, Hong Y, Hong M, Kim G, Lee J, Woo R, et al. Anti-inflammatory effects of neuregulin-1 in HaCaT keratinocytes and atopic dermatitis-like mice stimulated with Der p 38. Cytokine. 2024;174:156439 pubmed publisher
Podder A, Mohamed M, Tseropoulos G, Nasiri B, Andreadis S. Engineering Nanofiber Scaffolds with Biomimetic Cues for Differentiation of Skin-Derived Neural Crest-like Stem Cells to Schwann Cells. Int J Mol Sci. 2022;23: pubmed publisher
Yang H, Pan W, Xiao W, Yang M, Xu J, Li J, et al. Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms. BMC Psychiatry. 2022;22:217 pubmed publisher
Shin D, Kim S, Choi M, Bae Y, Han C, Choi B, et al. Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1. Oncogene. 2022;41:280-292 pubmed publisher
Mouton Liger F, Dumurgier J, Cognat E, Hourregue C, Zetterberg H, Vanderstichele H, et al. CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease. Alzheimers Res Ther. 2020;12:88 pubmed publisher
Wang S, Li R, Ng T, Luthria G, Oudin M, Prytyskach M, et al. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020;6:eaaz8521 pubmed publisher
Szułdrzyński K, Jankowski M, Potaczek D, Undas A. Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein. Dis Markers. 2020;2020:7190828 pubmed publisher
Ryu S, Lee J, Bae C, Moon C, Cho K. Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke. PLoS ONE. 2019;14:e0222587 pubmed publisher
Li C, Tao H, Yang X, Zhang X, Liu Y, Tang Y, et al. Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia. Int J Med Sci. 2018;15:900-906 pubmed publisher
Schwartz N, Pellach M, Glick Y, Gil R, Levy G, Avrahami D, et al. Neuregulin 1 discovered as a cleavage target for the HCV NS3/4A protease by a microfluidic membrane protein array. N Biotechnol. 2018;45:113-122 pubmed publisher
Miura Y, Sukawa Y, Hironaka S, Mori M, Nishikawa K, Tokunaga S, et al. Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2018;21:84-95 pubmed publisher
Buta C, Benabou E, Lequoy M, Régnault H, Wendum D, Meratbene F, et al. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res. 2016;35:126 pubmed publisher
Mukai H, Saeki T, Aogi K, Naito Y, Matsubara N, Shigekawa T, et al. Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Cancer Sci. 2016;107:1465-1470 pubmed publisher
Gijsen M, King P, Perera T, Parker P, Harris A, Larijani B, et al. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010;8:e1000563 pubmed publisher
Hickinson D, Marshall G, Beran G, Varella Garcia M, Mills E, South M, et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci. 2009;2:183-92 pubmed publisher
Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb J, et al. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci. 2010;30:5437-50 pubmed publisher
Hoffmann I, Bueter W, Zscheppang K, Brinkhaus M, Liese A, Riemke S, et al. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun. 2010;24:784-91 pubmed publisher
Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, et al. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis. Circ Res. 2009;105:500-10 pubmed publisher
Ky B, Kimmel S, Safa R, Putt M, Sweitzer N, Fang J, et al. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation. 2009;120:310-7 pubmed publisher
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed
product information
brand :
R&D Systems
master code :
DY377
SKU :
DY377-05
product name :
Neuregulin-1 beta 1/NRG1 beta 1 ELISA
sizes available :
1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
description :
The Human NRG1-beta 1/HRG1-beta 1 DuoSet ELISA from DY377-05 is a Solid Phase Sandwich ELISA that quantifies human .
target :
Neuregulin-1 beta 1/NRG1 beta 1
category :
ELISAs
dilution :
ELISA
species :
Human
gene symbol :
NRG1
kit type :
Solid Phase Sandwich ELISA
elisaRange :
125.00 - 4000 pg/mL
top caption :
Human Neuregulin-1 beta 1/ NRG1 beta 1 ELISA Standard Curve
applications :
ELISA
USD :
450 USD
alt names :
ARIA, GGF, GGF2, Heregulin-1, HGL, HRG, HRG1, HRG1-alpha, HRG1-beta 1, HRGA, MST131, MSTP131, NDF, neuregulin 1, Neuregulin1, Neuregulin1 beta 1, NRG1, NRG1-IT2, SMDF
storage :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.